HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergan acquiring Herald Pharmacal nonprescription skin care business.

This article was originally published in The Rose Sheet

Executive Summary

ALLERGAN ACQUIRING HERALD PHARMACAL SKIN CARE BUSINESS, for an undisclosed amount, Allergan announced Aug. 1. The companies have signed a definitive agreement regarding the acquisition. Herald Pharmacal markets a wide range of nonprescription glycolic acid-based skin care products. The M.D. Formulations brand is sold through dermatologists, plastic surgeons and aestheticians and the Aqua Glycolic line is marketed through pharmacies. Herald had sales of $15-20 mil. in fiscal 1995 ended July 31, according to Allergan.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel